Cancers of the stomach and esophagus compared to other organ specific cancers are much less prevalent, each accounting for less than 2% of newly diagnosed cancer cases each year. However, the stomach and esophagus are both vital organs in the digestive system, and for this reason treating these cancers effectively and efficiently, with as little damage and restriction of normal function as possible is vital for patient quality of life outcomes post surgery.
Surgical interventions are common with all cancers, and cancers of the esophagus and stomach are no different, but as mentioned above removing excessive sections of either organ will have potentially massive implications on patients, hence more research into refining, optimizing, and identifying novel ways of intervening surgically while protecting organ function is necessary.
This research topic aims to bring together emerging and novel ways of treating cancers by refining already existing surgical techniques including esophagojejunostomy, esophagectomy, transhiatal gastrectomy etc., as well as finding new ways to operate that can treat cancer which keep the patient’s postsurgical quality of life considerations at the fore.
We welcome Original Research, leading-edge Reviews and Clinical Trials related but not limited to the aspects below:
Novel surgical interventions to treat cancers of the stomach or esophagus
Intraoperative considerations improving postsurgical outcomes
post surgical approaches to improve healing rates
Refinements to existing surgical interventions leading to improved patient outcomes
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Cancers of the stomach and esophagus compared to other organ specific cancers are much less prevalent, each accounting for less than 2% of newly diagnosed cancer cases each year. However, the stomach and esophagus are both vital organs in the digestive system, and for this reason treating these cancers effectively and efficiently, with as little damage and restriction of normal function as possible is vital for patient quality of life outcomes post surgery.
Surgical interventions are common with all cancers, and cancers of the esophagus and stomach are no different, but as mentioned above removing excessive sections of either organ will have potentially massive implications on patients, hence more research into refining, optimizing, and identifying novel ways of intervening surgically while protecting organ function is necessary.
This research topic aims to bring together emerging and novel ways of treating cancers by refining already existing surgical techniques including esophagojejunostomy, esophagectomy, transhiatal gastrectomy etc., as well as finding new ways to operate that can treat cancer which keep the patient’s postsurgical quality of life considerations at the fore.
We welcome Original Research, leading-edge Reviews and Clinical Trials related but not limited to the aspects below:
Novel surgical interventions to treat cancers of the stomach or esophagus
Intraoperative considerations improving postsurgical outcomes
post surgical approaches to improve healing rates
Refinements to existing surgical interventions leading to improved patient outcomes
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.